Boost for global response to COVID-19 as economies formally sign up to COVAX facility


  • Priscilla Lynch
  • Univadis Medical News
L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano

The World Health Organization (WHO) has announced that 64 high income economies have now joined the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure eventual COVID-19 vaccines reach those in greatest need.

These countries will be joined by 92 low- and middle-income economies eligible for support to procure vaccines through the Gavi COVAX Advance Market Commitment (AMC). A total of 156 economies, representing roughly 64 per cent of the global population are now either committed to or eligible for the COVAX Facility, with more to follow.

With the agreements secured, the COVAX Facility will now start signing formal agreements with vaccine manufacturers and developers, which are partners in the COVAX effort, to secure the doses needed to end the acute phase of the pandemic by the end of 2021. The COVAX Facility will also maintain a buffer of doses for emergency and humanitarian use.

“COVID-19 is an unprecedented global crisis that demands an unprecedented global response,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “Vaccine nationalism will only perpetuate the disease and prolong the global recovery. Working together through the COVAX Facility is not charity, it’s in every country’s own best interests to control the pandemic and accelerate the global economic recovery.”